gms | German Medical Science

GMS Current Posters in Otorhinolaryngology - Head and Neck Surgery

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e.V. (DGHNOKHC)

ISSN 1865-1038

Head and neck malignant melanomas – clinical cases and treatment guidelines

Poster Onkologie

  • corresponding author Stefan Stoyanov - Ministry of Interior - Medical Institute, Sofia, Bulgaria
  • Georgi Chernev - MI-MI, Sofia, Bulgaria
  • Nikolay Damyanov - MI-MI, Sofia, Bulgaria
  • Iliya Lozev - MI-MI, Sofia, Bulgaria
  • Petar Kolev - MI-MI, Sofia, Bulgaria
  • Svetla Vasileva - MI-MI, Sofia, Bulgaria
  • Grigor Neofitov - MI-MI, Sofia, Bulgaria
  • Slavena Adamova - MI-MI, Sofia, Bulgaria
  • Katya Asenova - Military Medical Academy, Sofia, Bulgaria
  • Desislava Skerleva - Kyoto University, Kyoto, Japan

GMS Curr Posters Otorhinolaryngol Head Neck Surg 2017;13:Doc198

doi: 10.3205/cpo001752, urn:nbn:de:0183-cpo0017528

Veröffentlicht: 26. April 2017

© 2017 Stoyanov et al.
Dieser Artikel ist ein Open-Access-Artikel und steht unter den Lizenzbedingungen der Creative Commons Attribution 4.0 License (Namensnennung). Lizenz-Angaben siehe http://creativecommons.org/licenses/by/4.0/.


Gliederung

Abstract

Malignant melanomas are among the deadliest and fastest growing malignant tumors in human body. Although several decades ago they were considered rare, their frequency has increased dramatically in recent years.

Our aim is to present several of our own cases of malignant melanoma in head and neck area and outline treatment guidelines.

The extent of surgery is determined by the stage, location and size of the tumor: local excision; excision with sentinel lymph node biopsy; excision with selective modified or radical neck dissection. The advanced cases are treated by chemotherapy but the prognosis is poor. Promising seem to be the immuno-medications based on specific receptor antibodies.

Good collaboration with dermatologists is important for early diagnosis - a fundamental prerequisite for therapeutic success.

Der Erstautor gibt keinen Interessenkonflikt an.